| Year |
Citation |
Score |
| 2025 |
Muller A, Sullivan J, Schwarzer W, Wang M, Park-Windhol C, Hasler PW, Janeschitz-Kriegl L, Duman M, Klingler B, Matsell J, Hostettler SM, Galliker P, Hou Y, Balmer P, Virág T, ... ... Cronin T, et al. High-efficiency base editing in the retina in primates and human tissues. Nature Medicine. PMID 39779923 DOI: 10.1038/s41591-024-03422-8 |
0.573 |
|
| 2024 |
Mével M, Pichard V, Bouzelha M, Alvarez-Dorta D, Lalys PA, Provost N, Allais M, Mendes A, Landagaray E, Ducloyer JB, Toublanc E, Galy A, Brument N, Lefevre GM, Gouin SG, ... ... Cronin T, et al. Mannose-coupled AAV2: A second-generation AAV vector for increased retinal gene therapy efficiency. Molecular Therapy. Methods & Clinical Development. 32: 101187. PMID 38327809 DOI: 10.1016/j.omtm.2024.101187 |
0.55 |
|
| 2024 |
Leray A, Lalys PA, Varin J, Bouzelha M, Bourdon A, Alvarez-Dorta D, Pavageau K, Depienne S, Marchand M, Mellet A, Demilly J, Ducloyer JB, Girard T, Fraysse B, Ledevin M, ... ... Cronin T, et al. Novel chemical tyrosine functionalization of adeno-associated virus improves gene transfer efficiency in liver and retina. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 171: 116148. PMID 38232661 DOI: 10.1016/j.biopha.2024.116148 |
0.432 |
|
| 2023 |
Ducloyer JB, Pichard V, Mevel M, Galy A, Lefevre GM, Brument N, Alvarez-Dorta D, Deniaud D, Mendes-Madeira A, Libeau L, Le Guiner C, Cronin T, Adjali O, Weber M, Le Meur G. Intravitreal air tamponade after AAV2 subretinal injection modifies retinal EGFP distribution. Molecular Therapy. Methods & Clinical Development. 28: 387-393. PMID 36874242 DOI: 10.1016/j.omtm.2023.02.006 |
0.439 |
|
| 2021 |
Varin J, Morival C, Maillard N, Adjali O, Cronin T. Risk Mitigation of Immunogenicity: A Key to Personalized Retinal Gene Therapy. International Journal of Molecular Sciences. 22. PMID 34884622 DOI: 10.3390/ijms222312818 |
0.541 |
|
| 2020 |
Ducloyer JB, Le Meur G, Cronin T, Adjali O, Weber M. [Gene therapy for retinitis pigmentosa]. Medecine Sciences : M/S. 36: 607-615. PMID 32614312 DOI: 10.1051/medsci/2020095 |
0.448 |
|
| 2016 |
Ramachandran P, Lee V, Wei Z, Song JY, Casal G, Cronin T, Willett K, Huckfeldt R, Morgan JI, Aleman TS, Maguire AM, Bennett J. Evaluation of dose and safety of AAV7m8 and AAV8BP2 in the non-human primate retina. Human Gene Therapy. PMID 27750461 DOI: 10.1089/hum.2016.111 |
0.441 |
|
| 2014 |
Cronin T, Vandenberghe LH, Hantz P, Juttner J, Reimann A, Kacsó AE, Huckfeldt RM, Busskamp V, Kohler H, Lagali PS, Roska B, Bennett J. Efficient transduction and optogenetic stimulation of retinal bipolar cells by a synthetic adeno-associated virus capsid and promoter. Embo Molecular Medicine. 6: 1175-90. PMID 25092770 DOI: 10.15252/Emmm.201404077 |
0.658 |
|
| 2012 |
Cronin T, Chung DC, Yang Y, Nandrot EF, Bennett J. The Signalling Role of the avβ5-Integrin Can Impact the Efficacy of AAV in Retinal Gene Therapy. Pharmaceuticals (Basel, Switzerland). 5: 447-59. PMID 24281556 DOI: 10.3390/Ph5050447 |
0.68 |
|
| 2012 |
Jaillard C, Mouret A, Niepon ML, Clérin E, Yang Y, Lee-Rivera I, Aït-Ali N, Millet-Puel G, Cronin T, Sedmak T, Raffelsberger W, Kinzel B, Trembleau A, Poch O, Bennett J, et al. Nxnl2 splicing results in dual functions in neuronal cell survival and maintenance of cell integrity. Human Molecular Genetics. 21: 2298-311. PMID 22343139 DOI: 10.1093/Hmg/Dds050 |
0.53 |
|
| 2012 |
Cronin T, Lyubarsky A, Bennett J. Dark-rearing the rd10 mouse: implications for therapy. Advances in Experimental Medicine and Biology. 723: 129-36. PMID 22183325 DOI: 10.1007/978-1-4614-0631-0_18 |
0.6 |
|
| 2011 |
Stieger K, Cronin T, Bennett J, Rolling F. Adeno-associated virus mediated gene therapy for retinal degenerative diseases. Methods in Molecular Biology (Clifton, N.J.). 807: 179-218. PMID 22034031 DOI: 10.1007/978-1-61779-370-7_8 |
0.668 |
|
| 2011 |
Cronin T, Bennett J. Switching on the lights: the use of optogenetics to advance retinal gene therapy. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 1190-2. PMID 21720380 DOI: 10.1038/Mt.2011.115 |
0.612 |
|
| 2011 |
Fradot M, Busskamp V, Forster V, Cronin T, Léveillard T, Bennett J, Sahel JA, Roska B, Picaud S. Gene therapy in ophthalmology: validation on cultured retinal cells and explants from postmortem human eyes. Human Gene Therapy. 22: 587-93. PMID 21142470 DOI: 10.1089/Hum.2010.157 |
0.666 |
|
| 2009 |
Fridlich R, Delalande F, Jaillard C, Lu J, Poidevin L, Cronin T, Perrocheau L, Millet-Puel G, Niepon ML, Poch O, Holmgren A, Van Dorsselaer A, Sahel JA, Léveillard T. The thioredoxin-like protein rod-derived cone viability factor (RdCVFL) interacts with TAU and inhibits its phosphorylation in the retina. Molecular & Cellular Proteomics : McP. 8: 1206-18. PMID 19279044 DOI: 10.1074/Mcp.M800406-Mcp200 |
0.308 |
|
| 2008 |
O'Reilly M, Millington-Ward S, Palfi A, Chadderton N, Cronin T, McNally N, Humphries MM, Humphries P, Kenna PF, Farrar GJ. A transgenic mouse model for gene therapy of rhodopsin-linked Retinitis Pigmentosa. Vision Research. 48: 386-91. PMID 17920651 DOI: 10.1016/j.visres.2007.08.014 |
0.474 |
|
| 2007 |
O'Reilly M, Palfi A, Chadderton N, Millington-Ward S, Ader M, Cronin T, Tuohy T, Auricchio A, Hildinger M, Tivnan A, McNally N, Humphries MM, Kiang AS, Humphries P, Kenna PF, et al. RNA interference-mediated suppression and replacement of human rhodopsin in vivo. American Journal of Human Genetics. 81: 127-35. PMID 17564969 DOI: 10.1086/519025 |
0.368 |
|
| 2007 |
Cronin T, Léveillard T, Sahel JA. Retinal degenerations: from cell signaling to cell therapy; pre-clinical and clinical issues. Current Gene Therapy. 7: 121-9. PMID 17430131 DOI: 10.2174/156652307780363143 |
0.56 |
|
| Show low-probability matches. |